Uncover key drivers, emerging technologies, and competitive movements shaping the in-vitro colorectal cancer screening tests market from 2026–2035 with trusted insights from The Business Research Company
What level of CAGR-driven expansion is anticipated in the In-vitro Colorectal Cancer Screening Tests Market between 2026 and 2030?
The market for in-vitro colorectal cancer screening tests has experienced substantial growth recently. This market is projected to expand from $1.3 billion in 2025 to $1.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.7%. Historically, this growth has been driven by several factors, including rising colorectal cancer incidence rates, the expansion of population screening initiatives, heightened awareness of early cancer detection, the availability of laboratory-based diagnostic infrastructure, and advancements in biomarker identification.
The in-vitro colorectal cancer screening tests market is anticipated to experience substantial growth in the next few years, projected to reach $1.82 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.8%. The expansion during this forecast period is attributed to several factors, including the increasing adoption of personalized screening approaches, a rising demand for at-home diagnostic solutions, the expansion of preventive healthcare initiatives, the growing use of AI-assisted result interpretation, and an increasing focus on cost-effective cancer screening. Key trends expected over the forecast period involve the increasing adoption of non-invasive screening tests, a rising use of multi-target stool DNA testing, the growing integration of blood-based biomarker assays, an expansion of home-based sample collection kits, and an enhanced focus on early detection in asymptomatic populations.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27319&type=smp
What Drivers Are Affecting Demand-Supply Dynamics In The In-vitro Colorectal Cancer Screening Tests Market?
The increasing incidence of colorectal cancer is anticipated to fuel expansion within the in vitro colorectal cancer screening tests market in the future. This condition is characterized as a malignancy originating in the colon or rectum, frequently evolving from precancerous growths known as polyps. Its growing occurrence is linked to detrimental lifestyle choices, given that factors such as inadequate nutrition, insufficient physical activity, and excess weight elevate the likelihood of polyp formation and subsequent cancer progression. In-vitro screening tools assist in the diagnosis of colorectal cancer by providing non-invasive techniques for identifying early indicators of the disease. These tests boost the precision of screening by utilizing advanced biomarker identification, thereby improving the potential for timely intervention and better patient results. For example, the American Cancer Society, a US-based nonprofit body, reported an estimated 154,270 new colorectal cancer cases in February 2025, marking an increase from 152,810 cases in 2024. Consequently, the escalating prevalence of colorectal cancer is a key factor propelling the expansion of the in vitro colorectal cancer screening tests market.
What Segments Are Included Within The In-vitro Colorectal Cancer Screening Tests Market?
The in-vitro colorectal cancer screening tests market covered in this report is segmented –
1) By Test Type: Fecal Occult Blood Test, Stool Deoxyribonucleic Acid Test, Blood Biomarker Test, Other Test Types
2) By Imaging Type: In-vitro Confirmatory Diagnostics, Laboratory-Based Molecular Testing, Companion Diagnostic Testing, Genetic And Epigenetic Testing, Biomarker Validation Testing, Risk Stratification Assays
3) By Application: Screening, Diagnosis, Monitoring, Risk Assessment, Post-Treatment Surveillance
4) By End User: Hospitals, Diagnostic Laboratories, Outpatient Clinics, Home Care Settings, Research Institutions
Subsegments:
1) By Fecal Occult Blood Test: Guaiac Based Fecal Occult Blood Test, Immunochemical Fecal Occult Blood Test
2) By Stool Deoxyribonucleic Acid Test: Single Target Stool Deoxyribonucleic Acid Test, Multi Target Stool Deoxyribonucleic Acid Test
3) By Blood Biomarker Test: Methylated Septin 9 Deoxyribonucleic Acid Test, Circulating Tumor Deoxyribonucleic Acid Test, Protein Biomarker Based Blood Test
4) By Other Test Types: Urine Based Biomarker Test, Serum Based Biomarker Test, Breath Based Volatile Organic Compound Test
How Are Emerging Trends Affecting The Progression Of The In-vitro Colorectal Cancer Screening Tests Market?
Major companies within the in vitro colorectal cancer screening tests market are concentrating on developing advanced diagnostic solutions, such as multi-target stool DNA tests. This initiative aims to improve early detection accuracy, enhance patient convenience, and reduce colorectal cancer mortality rates. Multi-target stool DNA tests are innovative screening tools designed to analyze stool samples for genetic and biochemical markers associated with colorectal cancer and precancerous lesions. For example, in March 2025, Exact Sciences Corp., a US-based molecular diagnostics company, launched Cologuard Plus, an enhanced at-home colorectal cancer screening test for average-risk adults aged 45 and older. This test integrates advanced biomarker technology, providing higher sensitivity and specificity compared to its predecessor. It utilizes a refined algorithm to detect DNA mutations and hemoglobin biomarkers, thereby improving the detection of both colorectal cancer and advanced adenomas. The Cologuard Plus test offers a non-invasive and convenient screening option that eliminates the need for bowel preparation or dietary restrictions, consequently increasing patient adherence to recommended screening guidelines.
Who Are The Top-Performing Companies In The In-vitro Colorectal Cancer Screening Tests Market In Recent Years?
Major companies operating in the in-vitro colorectal cancer screening tests market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Quest Diagnostics Incorporated, Roche Diagnostics International AG, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Natera Inc., BGI Genomics Co. Ltd., NeoGenomics Inc., Guardant Health Inc., CellMax Life Inc., Epigenomics AG, Acuamark Diagnostics Inc., Beacon Biomedical Inc., Mainz Biomed NV, Hologic Inc., Danaher Corporation, Agilent Technologies Inc.
Access The Complete Report For Deeper Market Insights:
How Does The In-vitro Colorectal Cancer Screening Tests Market Perform Across Major Global Regions?
North America was the largest region in the in-vitro colorectal cancer screening tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro colorectal cancer screening tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized In-vitro Colorectal Cancer Screening Tests Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27319&type=smp
Browse Through More Reports Similar to the Global In-vitro Colorectal Cancer Screening Tests Market 2026, By The Business Research Company
Architectural Acoustic Panels Market Report 2026
https://www.thebusinessresearchcompany.com/report/architectural-acoustic-panels-global-market-report
Noise Mitigation System Market Report 2026
https://www.thebusinessresearchcompany.com/report/noise-mitigation-system-global-market-report
Automotive Noise Insulation Parts Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model